[Answered] A ________ is a variable-resistance sensor with three terminals.

This topic contains a solution. Click here to go to the answer

Author Question: A ________ is a variable-resistance sensor with three terminals. (Read 73 times)

mcmcdaniel

Hero Member
Posts: 550

on: Aug 13, 2021

Question 1

When testing the ECT sensor with the connector disconnected, the technician should select what position on the DMM?
◦ AC volts
◦ DC volts
◦ Ohms
◦ Hz (hertz)

Question 2

A ________ is a variable-resistance sensor with three terminals.
◦ Rheostat
◦ Potentiometer
◦ Thermistor
◦ Thyristor

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by mcmcdaniel on Aug 13, 2021

akudia

Sr. Member
Posts: 347

Reply #1 on: Aug 13, 2021

Answer 1

Ohms

Answer 2

Potentiometer

mcmcdaniel

Member
Posts: 550

Reply 2 on: Aug 13, 2021

Great answer, keep it coming

olderstudent

Member
Posts: 339

Reply 3 on: Yesterday

Gracias!

« previous next »

Did you know?

If you could remove all of your skin, it would weigh up to 5 pounds.

Did you know?

According to the Migraine Research Foundation, migraines are the third most prevalent illness in the world. Women are most affected (18%), followed by children of both sexes (10%), and men (6%).

Did you know?

There are major differences in the metabolism of morphine and the illegal drug heroin. Morphine mostly produces its CNS effects through m-receptors, and at k- and d-receptors. Heroin has a slight affinity for opiate receptors. Most of its actions are due to metabolism to active metabolites (6-acetylmorphine, morphine, and morphine-6-glucuronide).

Did you know?

Hippocrates noted that blood separates into four differently colored liquids when removed from the body and examined: a pure red liquid mixed with white liquid material with a yellow-colored froth at the top and a black substance that settles underneath; he named these the four humors (for blood, phlegm, yellow bile, and black bile).

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.